HER2-Low Breast Cancer: Current Landscape and Future Prospects
Author:
Publisher
Informa UK Limited
Reference118 articles.
1. Biochemistry of HER2 Oncogenesis in Breast Cancer
2. The basic biology of HER2
3. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
4. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group.
5. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patterns of treatment and outcomes of patients with metastatic HER2-low breast cancer treated with CDK4/6 inhibitors and hormone therapy;Drugs in Context;2025-05-07
2. Development and clinical evaluation of [68Ga]Ga-NODAGA-ADAPT6 as a novel HER2-targeted PET radiotracer for breast cancer imaging and treatment monitoring;European Journal of Nuclear Medicine and Molecular Imaging;2025-04-21
3. Redefining therapeutic landscapes: clinicopathological insights into low and ultra-low HER2 expression in male breast cancer;Diagnostic Pathology;2025-04-15
4. The impact of the new histological classification of breast cancer with the introduction of HER 2 low status;Journal of Gynecology Obstetrics and Human Reproduction;2025-04
5. Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer;Cancer Treatment Reviews;2025-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3